NOTTINGHAM, England, Dec. 4, 2025 /PRNewswire/ -- Quotient Sciences, a leading global drug development, research and manufacturing accelerator, and Intrepid Labs, the AI leader in pharmaceutical ...

Quotient Wealth Partners(“Quotient”) and TritonPoint Wealth (“TritonPoint”), today announced a joint partnership with Opto Investments, a technology-driven solution that streamlines the entire private ...

NOTTINGHAM, UK – 4th DECEMBER 2025: Quotient Sciences, a leading global drug development, research and manufacturing accelerator, and Intrepid Labs, the AI leader in pharmaceutical formulation science ...

DALLAS & WASHINGTON, December 03, 2025--(BUSINESS WIRE)--Quotient Wealth Partners ("Quotient") and TritonPoint Wealth ("TritonPoint"), today announced a joint partnership with Opto Investments, a ...